首页 | 本学科首页   官方微博 | 高级检索  
检索        


Survival of a hepatitis C virus surrogate in anaesthetic and analgesic drugs
Institution:1. Clinic for Intensive Care Medicine, University Hospital Basel, Switzerland;2. Division of Clinical Neurophysiology, Department of Neurology, University Hospital Basel, Basel, Switzerland;3. Department of Neurology, Johns Hopkins Bayview Medical Center, Baltimore, MD, USA;1. Department of Neurosurgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, North 15 West 7, Kita-ku, Sapporo, Hokkaido 060-8638, Japan;2. Department of Neurosurgery, Hokkaido Neurosurgical Memorial Hospital, Sapporo, Japan
Abstract:The re-use of solutions used in surgical procedures provides an opportunity for transmission of infectious agents should a breakdown in good work practices occur. Agents that are blood-borne are particularly important in this respect. We examined whether a hepatitis C virus surrogate (bovine viral diarrhoeal virus) could survive exposure to Propafol and Fentanyl, drugs commonly used for induction of anaesthesia and analgesia, respectively. Testing involved the spiking of ampoules of these solutions with a high-titred preparation of virus. Following incubation of this mixture at ambient temperature for various periods of time, attempts were made to isolate the virus in cell cultures. Our results showed that the surrogate virus survived for up to 2 hours without loss of titre in these solutions, suggesting that the hepatitis C virus would also survive and could also be transmitted in a surgical setting under some circumstances.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号